Search

Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.

71 study records (showing up to 30 per record type)

• Registered trial NCT06138470 Not completed: Recruiting
  Evaluation of the Effect of a Combination of Plants to Regulate Mood
  Condition or outcome area: Mood Regulation
  2022-05-30 · Subject: Xi Hong Hua; 西红花; Saffron; Croci Stigma;Stigma Croci · open the herb record · ClinicalTrials.gov
• Registered trial NCT05933460 Completed (results not assessed here)
  Crocus Sativus Extract Impact in Metabolic Control of Patients With Diabetes Mellitus Type 1
  Condition or outcome area: Diabetes Mellitus, Type 1|Diabetes type1
  2022-03-01 · Subject: Xi Hong Hua; 西红花; Saffron; Croci Stigma;Stigma Croci · open the herb record · ClinicalTrials.gov
• Registered trial NCT05696665 Not completed: Recruiting
  Role of Saffron and Chamomile in the Management of Parkinson's Disease
  Condition or outcome area: Parkinson Disease|Neurodegenerative Diseases
  2022-07-05 · Subject: Xi Hong Hua; 西红花; Saffron; Croci Stigma;Stigma Croci · open the herb record · ClinicalTrials.gov
• Registered trial NCT05690126 Not completed: Recruiting
  Effect of Saffron Extract Supplementation on Emotional Well-being Alterations
  Condition or outcome area: Mood Disturbance
  2022-12-08 · Subject: Xi Hong Hua; 西红花; Saffron; Croci Stigma;Stigma Croci · open the herb record · ClinicalTrials.gov
• Registered trial NCT05484362 Completed (results not assessed here)
  Acute Effect of Crocus Sativus on Postprandial Glycemia
  Condition or outcome area: Potential Abnormality of Glucose Tolerance|Appetitive Behavior|Blood Pressure
  2022-06-06 · Subject: Xi Hong Hua; 西红花; Saffron; Croci Stigma;Stigma Croci · open the herb record · ClinicalTrials.gov
• Registered trial NCT05572749 Completed (results not assessed here)
  Clinical Trial of Crocus Kozanis Administration in Obese Children and Adolescents
  Condition or outcome area: PreDiabetes|Obesity|Dyslipidemias
  2021-05-01 · Subject: Xi Hong Hua; 西红花; Saffron; Croci Stigma;Stigma Croci · open the herb record · ClinicalTrials.gov
• Registered trial NCT01590485 Completed (results not assessed here)
  Evaluation of the Effect of Saffron (Crocus Sativus) on Pain Control After Root Canal Therapy in Teeth With Vital Pulps
  Condition or outcome area: Post-treatment Pain Following Root Canal Therapy
  2012-05 · Subject: Xi Hong Hua; 西红花; Saffron; Croci Stigma;Stigma Croci · open the herb record · ClinicalTrials.gov
• Registered trial NCT04749576 Not completed: Unknown
  Saffron as Anti Inflammatory Agent In Patients With Inflammatory Bowel Disease
  Condition or outcome area: Ulcerative Colitis
  2020-12-15 · Subject: Xi Hong Hua; 西红花; Saffron; Croci Stigma;Stigma Croci · open the herb record · ClinicalTrials.gov
• Registered trial NCT04750681 Completed (results not assessed here)
  Evaluation of the Effects of Saffron Extract on Sleep Quality and Stress
  Condition or outcome area: Insomnia|Stress
  2019-08-12 · Subject: Xi Hong Hua; 西红花; Saffron; Croci Stigma;Stigma Croci · open the herb record · ClinicalTrials.gov
• Registered trial NCT01625442 Phase 4 Completed (results not assessed here)
  Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) in Metabolic Syndrome
  Condition or outcome area: Metabolic Syndrome|Hypercholesterolemia|Hypertriglyceridemia|Hyperglycemia
  2010-01 · Subject: Xi Hong Hua; 西红花; Saffron; Croci Stigma;Stigma Croci · open the herb record · ClinicalTrials.gov
• Registered trial NCT01625442 Phase 4 Completed (results not assessed here)
  Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) in Metabolic Syndrome
  Condition or outcome area: Metabolic Syndrome|Hypercholesterolemia|Hypertriglyceridemia|Hyperglycemia
  2010-01 · Subject: Ou Zhou Xiao Bo; 欧洲小檗; European Barberry; Berberis Vulgaris · open the herb record · ClinicalTrials.gov
• Systematic review registration CRD42023492107 Registered protocol, no results here: Review Ongoing
  Meta-analysis of the antioxidant capacity of Curcumin Bioactive compounds
  Condition or outcome area: The antioxidant capacity expressed by changes in the function and metabolites of all enzymes in charge of the oxidative process in humans
  2023-12-21 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023491610 Registered protocol, no results here: Review Ongoing
  Effectiveness of Herbal Treatments in Cervicovaginal HPV Infection: Meta-Analysis of Randomized Studies
  Condition or outcome area: Servicovaginal HPV
  2023-12-25 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023490581 Registered protocol, no results here: Review Ongoing
  Efficacy of antioxidant-based pharmacological therapies in Autism Spectrum Disorder: A Systematic Review
  Condition or outcome area: Symptom management in patients with ASD
  2023-12-16 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023487941 Registered protocol, no results here: Review Ongoing
  Demethoxycurcumin and bisdemethoxycurcumin are more bioavailable than curcumin in healthy humans: a systematic literature review and meta-analysis
  Condition or outcome area: Turmeric is widely used as a spice but it has also long been used as a traditional medicine and it is used in many dietary supplements. Turmeric usually contains a mixture of three main curcuminoid species: curcumin, demethoxycurcumin and bisdemethoxycurcumin. Curcumin has been the focus of many studies, including randomized controlled trials, investigating numerous potential effects against e.g. inflammation, oxidative stress, cancer, metabolic syndrome, cognitive function decline/Alzheimer’s d
  2023-12-12 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023483768 Registered protocol, no results here: Review Ongoing
  ROLE OF CURCUMIN AND ITS NANOFORMULATIONS IN THE MANAGEMENT OF ORAL SQUAMOUS CELL CARCINOMA: A SYSTEMATIC REVIEW
  Condition or outcome area: Oral squamous cell carcinoma (OSCC) is the most common type of oral malignancy, accounting for approximately 80-90% of all malignant neoplasms in the oral cavity. The incidence of oral cancer can vary significantly worldwide, with the oral cavity ranging from the 6th to the 9th most common location for cancer, depending on the country and even specific regions within a country. The incidence of oral cancer is also influenced by factors such as gender and lifestyle choices like tobacco and alcoho
  2023-11-30 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023482358 Registered protocol, no results here: Review Ongoing
  Curcumin, a bioactive supplement for Premenstrual Syndrome and Dysmenorrhea- A Systematic Review of randomized clinical trials
  Condition or outcome area: Premenstrual syndrome (PMS) and dysmenorrhea are prevalent gynecological conditions that affect a significant portion of women worldwide. PMS manifests as a range of physical, emotional, and behavioral symptoms that precede menstruation, while dysmenorrhea is characterized by pain and discomfort during menstruation. Curcumin, a natural compound derived from turmeric, has emerged as a potential therapeutic option due to its diverse pharmacological properties, including anti-inflammatory, antiprol
  2023-11-23 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023479695 Registered protocol, no results here: Review Ongoing
  Anti-tumor effects of curcumin on leukemia: a systematic review
  2023-12-12 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023479195 Registered protocol, no results here: Review Ongoing
  Systematic Review of Curcumin Supplementation on Iron Overload and Antioxidant effect in Beta Thalassemia Patients
  Condition or outcome area: Beta thalassemia major, or cooley's anemia, is the most severe type of the condition. Two beta-globin genes are either absent or broken in this condition. Because individuals with beta thalassemia major require ongoing blood transfusions, the disorder is now referred to as "transfusion-dependent thalassemia
  2023-11-20 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023476932 Registered protocol, no results here: Review Ongoing
  Clinical efficacy and acceptability of natural products in management of radiotherapy-induced oral mucositis: A systematic review
  Condition or outcome area: Radiotherapy-induced oral mucositis
  2023-11-12 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023470083 Registered protocol, no results here: Review Ongoing
  Effectiveness and safety of Curcumin in Autoimmune and Rheumatic Diseases
  Condition or outcome area: Autoimmune and Rheumatic Diseases Curcumin in Autoimmune and Rheumatic Diseases
  2023-10-17 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023469615 Registered protocol, no results here: Review Ongoing
  Premenstrual syndrome attenuation with curcumin: A systematic review and Meta-Analysis
  Condition or outcome area: Premenstrual Syndrome (PMS) is a common condition affecting women, characterized by physical and psychological symptoms tied to hormonal fluctuations in the menstrual cycle. It can range from mild to severe. Medications are often used to alleviate symptoms, but their side effects can be problematic. Curcumin, a compound found in turmeric, has shown promise in reducing PMS symptoms by affecting prostaglandin levels and neurotransmitters, offering a potential natural remedy.
  2023-10-15 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023464474 Registered protocol, no results here: Review Ongoing
  EFFICACY OF CURCUMA LONGA IN RELIEVING PAIN SYMPTOM OF KNEE OSTEOARTHRITIS PATIENTS: A META ANALYSIS OF CLINICAL TRIALS
  Condition or outcome area: Knee osteoarthritis
  2023-10-11 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023463126 Registered protocol, no results here: Review Ongoing
  Nutri-epigenetic effect of curcumin on the treatment of prostate cancer: a systematic review
  2023-11-29 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023462329 Registered protocol, no results here: Review Ongoing
  Efficacy and safety of adjuvant curcumin therapy in colorectal cancer: A systematic review and meta-analysis
  Condition or outcome area: In the most promising therapeutic progress recently, curcumin, a polyphenol from Curcuma, has been suggested to obtain many health-related benefits and pharmacological effects, including its anti-inflammatory and anti-cancer effects. Curcumin is a candidate drug for the prevention and treatment of colorectal cancer.Curcuminoids supplementation for a period of 8 weeks (500 mg/day) can improve ESR and serum levels of CRP in stage-3 CRC subjects and improve the global quality of life and functional
  2023-09-21 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023462093 Registered protocol, no results here: Review Ongoing
  The potential role of turmeric and curcumin as treatment agent for osteoarthritis: A systematic review
  Condition or outcome area: Patients with osteoarthritis condition
  2023-09-29 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023460995 Registered protocol, no results here: Review Ongoing
  Curmin and photoprotection: a systematic review
  Condition or outcome area: The skin is the largest human organ and is the main organ exposed to the harmful effects of exposure to ultraviolet radiation. However, the use of substances with photoprotective properties can prevent the onset of photoaging and skin cancer.
  2023-09-16 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023457942 Registered protocol, no results here: Review Ongoing
  A systematic review and meta-analysis of randomized clinical trials on Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients
  Condition or outcome area: we summarize earlier findings for the effect of curcumin supplementation on glycaemic indices, lipid profile, blood pressure, inflammatory markers, and anthropometric measurements of NAFLD patients.
  2023-09-06 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023454540 Registered protocol, no results here: Review Ongoing
  Pre-clinical Evidence: curcumin as a promising candidate for inhibition of liver cancer growth, a systematic review, and meta-analysis
  2023-09-06 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023448750 Registered protocol, no results here: Review Ongoing
  Effectiveness of Curcumin in Sarcopenia
  Condition or outcome area: Sarcopenia is a progressive and generalized skeletal muscle disorder associated with an increased likelihood of adverse outcomes, including falls, fractures, physical disability, and mortality.
  2023-08-05 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023448363 Registered protocol, no results here: Review Ongoing
  The efficacy and safety of oral curcumin therapy in patients with cancer: a systematic review and meta-analysis.
  Condition or outcome area: Cancer deaths account for 21% of all cases in the U.S. and cancer is the second leading cause of death worldwide.
  2023-08-05 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023448196 Registered protocol, no results here: Review Ongoing
  Antioxidants effects of Curcumin supplementation in among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis
  Condition or outcome area: Metabolic syndrome factors is a broad term referred to several aspects of human health including antioxidants markers
  2023-08-05 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023447628 Registered protocol, no results here: Review Ongoing
  Targeting cognitive function with curcumin in humans: A systematic review and meta-analysis
  Condition or outcome area: The association of curcumin with cognitive function in humans.
  2023-08-02 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023447460 Registered protocol, no results here: Review Ongoing
  Anti-inflammatory effects of Curcumin supplementation in among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis
  Condition or outcome area: Metabolic syndrome factors is a broad term referred to several aspects of human health including inflammatory markers.
  2023-08-01 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023446682 Registered protocol, no results here: Review Ongoing
  Chemopreventive efficacy of Curcumin in the management of Oral submucous fibrosis- A systematic review
  Condition or outcome area: Oral submucous fibrosis (OSMF) is a potentially malignant disorder of oral cavity primarily caused by areca nut chewing. Prevalence of OSMF is reported between .03% and 30% irrespective of areca nut habit. OSMF is a major global health issue because of its high malignant transformation rate, upto 15-30% according to different studies.OSMF is characterized by burning sensation on having hot and spicy food and stiffness and blanching of the oral mucosa leading to restricted mouth opening.
  2023-07-31 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023441075 Registered protocol, no results here: Review Ongoing
  Curcumin and cognitive impairment: A systematic review and meta-analysis
  Condition or outcome area: cognitive impairment
  2023-07-10 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023440612 Registered protocol, no results here: Review Ongoing
  Effects of turmeric/curcumin supplementation on anthropometric indices in subjects with prediabetes and type 2 diabetes mellitus: A systematic review and dose-response meta-analysis of randomized controlled Trials
  Condition or outcome area: In this review, the effect of turmeric/curcumin on body composition in patients with prediabetes and type 2 diabetes mellitus will be studied.
  2023-07-10 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023439718 Registered protocol, no results here: Review Ongoing
  Curcumin as a potential agent for inhibition of glioma growth: a systematic review and meta-analysis
  2023-07-05 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023439564 Registered protocol, no results here: Review Ongoing
  Effects of curcumin nanoparticles on cognitive impairment in Alzheimer's disease: a systematic review and meta-analysis of preclinical studies
  2023-07-05 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023432665 Registered protocol, no results here: Review Ongoing
  Mapping and exploring the therapeutic potential of natural bioactive compound Curcumin in NAFLD: A Systematic Review & Meta-Analysis
  Condition or outcome area: NonAlcoholic Fatty Liver Disease Nonalcoholic fatty liver disease (NAFLD) is a condition in which excess fat builds up in the liver.
  2023-06-16 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42023426108 Registered protocol, no results here: Review Ongoing
  Efficacy and safety of curcumin therapy in the treatment of knee osteoarthritis: A Bayesian network meta-analysis
  Condition or outcome area: Knee osteoarthritis (KOA) is a degenerative osteoarthritis characterized by joint inflammation and progressive articular cartilage degeneration. The main clinical manifestations of KOA are joint swelling, pain, stiffness, and limited mobility, which seriously affect patients' self-care ability and reduce their quality of life.
  2023-05-23 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Publication PMID 36676983 Research model: Cell Experiment
  Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines
  Condition or outcome area: Chronic myeloid leukemia; myeloproliferative haematological malignancy
  Metabolites · 2023 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3390/metabo13010058
• Publication PMID 36610148 Research model: Animal & Cell Experiment
  Curcumin treatment suppresses cachexia-associated adipose wasting in mice by blocking the cAMP/PKA/CREB signaling pathway
  Condition or outcome area: cancer cachexia; Cachexia; adipose atrophy; tumor; C26 tumors; cachexia; cancer
  Phytomedicine · 2023 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.1016/j.phymed.2022.154563
• Publication PMID 36552609 Research model: Animal Experiment
  β-Cell Autophagy Pathway and Endoplasmic Reticulum Stress Regulating-Role of Liposomal Curcumin in Experimental Diabetes Mellitus: A Molecular and Morphometric Study
  Condition or outcome area: type I diabetes
  Antioxidants (Basel) · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3390/antiox11122400
• Publication PMID 36538966 Research model: Cell Experiment
  Effective role of Curcumin on expression regulation of EZH2 histone methyltransferase as a dynamic epigenetic factor in osteogenic differentiation of human mesenchymal stem cells
  Condition or outcome area: osteogenesis
  Biochim Biophys Acta Gene Regul Mech · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.1016/j.bbagrm.2022.194903
• Publication PMID 36499098 Research model: Cell Experiment
  New Insights into Dose-Dependent Effects of Curcumin on ARPE-19 Cells
  Condition or outcome area: Age-Related Macular Degeneration; proliferative vitreoretinopathy; ocular diseases
  Int J Mol Sci · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3390/ijms232314771
• Publication PMID 36432477 Research model: Clinical Experiment
  MACC1-Dependent Antitumor Effect of Curcumin in Colorectal Cancer
  Condition or outcome area: tumor; colon cancer; cancer; colorectal cancer
  Nutrients · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3390/nu14224792
• Publication PMID 36359867 Research model: Cell Experiment
  Curcumin Reprograms TAMs from a Protumor Phenotype towards an Antitumor Phenotype via Inhibiting MAO-A/STAT6 Pathway
  Condition or outcome area: tumor
  Cells · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3390/cells11213473
• Publication PMID 36353208 Research model: Animal & Cell Experiment
  Curcumin alleviates experimental colitis via a potential mechanism involving memory B cells and Bcl-6-Syk-BLNK signaling
  Condition or outcome area: Immune dysfunction; Colitis; autoimmune diseases; colitis; inflammatory bowel disease
  World J Gastroenterol · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3748/wjg.v28.i40.5865
• Publication PMID 36300880 Research model: Cell Experiment
  Modulation of the activity of histone lysine methyltransferases and demethylases by curcumin analog in leukaemia cells
  Condition or outcome area: HKDMs; cancer
  J Cell Mol Med · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.1111/jcmm.17589
• Publication PMID 36243116 Research model: Cell Experiment
  The effect of curcumin on the cadmium-induced mitochondrial apoptosis pathway by metallothionein 2A regulation
  Life Sci · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.1016/j.lfs.2022.121076
• Publication PMID 36238646 Research model: Animal & Cell Experiment
  Curcumin Enhanced Ionizing Radiation-Induced Immunogenic Cell Death in Glioma Cells through Endoplasmic Reticulum Stress Signaling Pathways
  Condition or outcome area: glioma; immunogenic cell death; tumor
  Oxid Med Cell Longev · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.1155/2022/5424411
• Publication PMID 36237434 Research model: Cell Experiment
  Curcumin affects function of Hsp90 and drug efflux pump of Candida albicans
  Condition or outcome area: cancer; candidiasis
  Front Cell Infect Microbiol · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3389/fcimb.2022.944611
• Publication PMID 36196887 Research model: Animal & Cell Experiment
  Effect of curcumin on regulatory B cells in chronic colitis mice involving TLR/MyD88 signaling pathway
  Condition or outcome area: colitis; ulcerative colitis; chronic colitis
  Phytother Res · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.1002/ptr.7656
• Publication PMID 36155114 Research model: Cell Experiment
  Curcumin and capsaicin regulate apoptosis and alleviate intestinal inflammation induced by Clostridioides difficile in vitro
  Condition or outcome area: Clostridioides difficile infection
  Ann Clin Microbiol Antimicrob · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.1186/s12941-022-00533-3
• Publication PMID 36120325 Research model: Clinical & Animal Experiment
  Efficacy and safety of curcumin in psoriasis: preclinical and clinical evidence and possible mechanisms
  Condition or outcome area: psoriatic dermatitis; tumor; chronic and immune-mediated inflammatory skin disease; psoriasis; Psoriasis
  Front Pharmacol · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3389/fphar.2022.903160
• Publication PMID 36014807 Research model: Cell Experiment
  Cinnamaldehyde and Curcumin Prime Akt2 for Insulin-Stimulated Activation
  Condition or outcome area: insulin resistance syndrome
  Nutrients · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3390/nu14163301
• Publication PMID 36007676 Research model: Cell Experiment
  Mechanism of apoptosis activation by Curcumin rescued mutant p53Y220C in human pancreatic cancer
  Condition or outcome area: tumor; pancreatic cancer; tumors
  Biochim Biophys Acta Mol Cell Res · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.1016/j.bbamcr.2022.119343
• Publication PMID 35955792 Research model: Animal & Cell Experiment
  Dual Mechanism of Action of Curcumin in Experimental Models of Multiple Sclerosis
  Condition or outcome area: inflammation; autoimmune encephalomyelitis; Multiple sclerosis; demyelination
  Int J Mol Sci · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3390/ijms23158658
• Publication PMID 35897820 Research model: Cell Experiment
  Curcumin Induces Apoptosis of Chemoresistant Lung Cancer Cells via ROS-Regulated p38 MAPK Phosphorylation
  Condition or outcome area: lung cancer; chemoresistant human lung cancer
  Int J Mol Sci · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3390/ijms23158248
• Publication PMID 35884410 Research model: Cell Experiment
  The Role of Curcumin in Prostate Cancer Cells and Derived Spheroids
  Condition or outcome area: mCRPC; prostate cancer; tumor
  Cancers (Basel) · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3390/cancers14143348
• Publication PMID 35882275 Research model: Animal & Cell Experiment
  Curcumin induces mitochondrial apoptosis in human hepatoma cells through BCLAF1-mediated modulation of PI3K/AKT/GSK-3β signaling
  Condition or outcome area: hepatoma; tumor
  Life Sci · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.1016/j.lfs.2022.120804
• Publication PMID 35780999 Research model: Animal Experiment
  Hepatoprotective effect of curcumin against bisphenol A-induced hepatic steatosis via modulating gut microbiota dysbiosis and related gut-liver axis activation in CD-1 mice
  Condition or outcome area: BPA-mediated hepatic steatosis; hepatic steatosis; microbial dysbiosis
  J Nutr Biochem · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.1016/j.jnutbio.2022.109103
• Publication PMID 35772713 Research model: Clinical & Animal Experiment
  Sensitization of GSH synthesis by curcumin curtails acrolein-induced alveolar epithelial apoptosis via Keap1 cysteine conjugation: A randomized controlled trial and experimental animal model of pneumonitis
  Condition or outcome area: pneumonitis; Pneumonitis; chronic obstructive pulmonary disease; respiratory diseases
  J Adv Res · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.1016/j.jare.2022.06.013
• Publication PMID 35745868 Research model: Animal Experiment
  Formulated Curcumin Prevents Paclitaxel-Induced Peripheral Neuropathy through Reduction in Neuroinflammation by Modulation of α7 Nicotinic Acetylcholine Receptors
  Condition or outcome area: burning pain; peripheral neuropathy; Paclitaxel-induced peripheral neuropathy; peripheral neuropathies; mechanical allodynia; solid malignancies
  Pharmaceutics · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3390/pharmaceutics14061296
• Publication PMID 35739979 Research model: Animal Experiment
  Alleviation of Oral Exposure to Aflatoxin B1-Induced Renal Dysfunction, Oxidative Stress, and Cell Apoptosis in Mice Kidney by Curcumin
  Condition or outcome area: renal dysfunction; renal injury
  Antioxidants (Basel) · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3390/antiox11061082
• Publication PMID 35706905 Research model: Cell Experiment
  Curcumin Blocks High Glucose-Induced Podocyte Injury via RIPK3-Dependent Pathway
  Condition or outcome area: podocyte injuries; diabetic nephropathy; hyperglycemic; podocyte loss
  Front Cell Dev Biol · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3389/fcell.2022.800574
• Publication PMID 35624801 Research model: Animal Experiment
  Long-Term Feeding with Curcumin Affects the Growth, Antioxidant Capacity, Immune Status, Tissue Histoarchitecture, Immune Expression of Proinflammatory Cytokines, and Apoptosis Indicators in Nile Tilapia, Oreochromis niloticus
  Antioxidants (Basel) · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3390/antiox11050937
• Publication PMID 35609329 Research model: Animal & Cell Experiment
  Curcumin alleviates rheumatoid arthritis progression through the phosphatidylinositol 3-kinase/protein kinase B pathway: an in vitro and in vivo study
  Condition or outcome area: chronic, systemic autoimmune disease; joint inflammation; Rheumatoid arthritis; arthritis; collagen-induced arthritis; Arthritis; synovial inflammation; hind paw edema; joint bone and cartilage destruction
  Bioengineered · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.1080/21655979.2022.2078942
• Publication PMID 35571134 Research model: Animal & Cell Experiment
  Curcumin Restrains Oxidative Stress of After Intracerebral Hemorrhage in Rat by Activating the Nrf2/HO-1 Pathway
  Condition or outcome area: neurological injury; Intracerebral hemorrhage; hemorrhagic stroke; cerebral oxidative stress
  Front Pharmacol · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3389/fphar.2022.889226
• Publication PMID 35565795 Research model: Animal & Cell Experiment
  Curcumin Supplementation Ameliorates Bile Cholesterol Supersaturation in Hamsters by Modulating Gut Microbiota and Cholesterol Absorption
  Nutrients · 2022 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.3390/nu14091828